Unlocking impact at scale
We believe in achieving health equity through innovation, and look for like-minded founders who are pioneering the future of healthcare.
InHealth Ventures invests in companies that will increase patient access, improve clinical outcomes and reduce the costs associated with care delivery.
In evaluating companies, we typically look for:
We’re looking for founding teams that have a unique insight into the problem they’ve identified, and a distinctive approach around how they’re solving it. You need not be a healthcare insider, but should have developed a strong picture of the stakeholders, economic incentives and key enablers for success in the market in which you’re operating.
A clear articulation of the opportunity
Health systems across the world have a lot in common. There are also crucial distinctions. We invest in companies targeting problems that are universal, allowing them to build global businesses over the long-term. We’re looking for a clear, top-down, perspective on why the market is promising and a strong bottom-up analysis demonstrating its size and how to access.
A compelling value proposition with a route to scale
Scaling in healthcare can be a brutally complex endeavour. Difficulties often come back to problems with the strength of the value proposition across different markets and geographies. We get excited about product visions that create a step-change in impact for a range of stakeholders – whether clinical, operational or financial – across healthcare and life sciences. We also want to understand not just how a product or service will create value, but how it can capture value at scale.
We invest in…
Technology-enabled healthcare and life sciences
We get excited about next-generation infrastructure, tech-enabled services and software-based diagnostic and therapeutic platforms.
We back companies from pre-seed to series A. We both lead and co-invest in deals, and typically write $500K - $3M cheques, reserving additional capital to follow-on in subsequent rounds.
We primarily invest in the UK, US and Europe, but we are not limited by geography.